James Anderson

[AMR Action Fund @AMRActionFund]

Antibiotic development “is a specialist field, and it takes a long time for people to build up that expertise. So again, there is an urgency to try and stop that brain drain before it's lost further.” Insightful @CIDRAP Q&A w/@AndersonJames34 https://t.co/dEf1EnurJh #AMR

[Working to Fight AMR @WeFightAMR]

Fewer than 30 #antibiotics currently in development target #drugresistant bacteria identified by the @WHO as the highest priority. More in @sciam:
https://t.co/iEEn6z9ViQ

[Save Antibiotics @saveantibiotics]

"This is an area of true need. There has not been a new #antibiotic approved for the treatment of S. aureus bacteremia for over 15 years," @DukeMedSchool’s Thomas Holland, MD, says. https://t.co/bew4lFwRZP

[Prof. Dame Sally Davies @UKAMREnvoy]

This week, I am in New York for the United Nations General Assembly Week 🗽

With three High-Level Meetings on global health and half time for realising the Sustainable Development Goals, we now need to galvanise and look ahead to next year’s meeting on AMR 💊

[IFPMA @IFPMA]

New @IPPSecretariat comment published by @TheLancet on delivering the #100DaysMission. It’s critical that we learn the right lessons from the #COVID19 response to better prepare for future pandemics. Read @IFPMA’s priorities here: https://t.co/RaMF7y11g4

[IFPMA @IFPMA]

#Cancer and #AMR are interlinked, as cancer patients' weakened immune systems leave them unprepared to fight off superbugs.

Incentives for #antibiotics R&D can help us address these "twin epidemics."⤵️https://t.co/6yQzlHpo65

[Save Antibiotics @saveantibiotics]

“As more drug-resistant diseases, such as #gonorrhea, staphylococcus infections and strains of tuberculosis become increasingly persistent, time is not on our side.” –@innovativemeds @pcfralick https://t.co/DtwjPO0t9b

[IFPMA @IFPMA]

Progress in #globalhealth means people can live longer and healthier lives.

Our collaborations help drive different activities in low- and middle-income countries that contribute toward #UHC and #HealthforAll🌎.

Explore them on https://t.co/YSw5iv9zmB

[Global AMR Research & Development (R&D) Hub @GlobalAMRHub]

Thanks to @CSEINDIA for organising a great discussion and for the invitation to take part!

We need to collaborate, co-operate and innovate to solve the antibiotic development and access crisis.

#AMR #stopsuperbugs #antibiotics #antibacterials
#pushfunding #pullincentives

[Jeremy Knox @_Jeremy_Knox]

What could the next two decades of change look like in the infectious disease R&D ecosystem?

New discussion paper from the @wellcometrust policy team sets out a vision for ambitious transformation - to help ensure we have the tools 💉💊🔬 we need to face 📈 infections 👇
(1/3)

[IFPMA @IFPMA]

📢 Mark your calendars! On the sidelines of the #WHA76 (21-30 May, Geneva), IFPMA is organizing a series of events on #UHC, clinical trials, and #digitalhealth.

Information are updated regularly on our website, check it out!👇

https://t.co/UlwrYcZCA📢 Mark your calendars! On the sidelines of the #WHA76 (21-30 May, Geneva), IFPMA is organizing a series of events on #UHC, clinical trials, and #digitalhealth.

Information are updated regularly on our website, check it out!👇

https://t.co/UlwrYcZCA📢 Mark your calendars! On the sidelines of the #WHA76 (21-30 May, Geneva), IFPMA is organizing a series of events on #UHC, clinical trials, and #digitalhealth.

Information are updated regularly on our website, check it out!👇

https://t.co/UlwrYcZCAQ

[AMR Action Fund @AMRActionFund]

“If we don’t get some policy changes and develop the right financial incentives to reward risk taking,” CEO Henry Skinner said, “then the little innovation we have will, I think, dry up nearly completely.” #AMR

https://t.co/SCDmWccJj9

[AMR Action Fund @AMRActionFund]

Policymakers must act now on #AMR “because, without timely interventions, investors will continue putting their money into other therapeutic areas; antibiotic companies will go bankrupt; and patients will continue suffering,” writes @JohnAlterIII https://t.co/qEB2fwQ2u7

[AMR Action Fund @AMRActionFund]

“No other class of drugs has served humanity’s collective interests like antibiotics have. Yet, they remain dangerously undervalued in today’s marketplace,” writes @HeideckerMartin #AMR https://t.co/wzl19WqbwI via @HealthEuropa

[IFPMA @IFPMA]

Science & innovation delivered medical countermeasures to fight against #COVID19 in record time, but discussions on weakening IP protections risk hindering the #innovation system that enabled this in the first place.

@ThomasCueni in @swissinfo_en⬇️ https://t.co/ONG6DtDsQS

[James Anderson @AndersonJames34]

Pleased to take part in this important meeting and share the progress made by the private sector as well as the asks we have to governments globally

[Chris Fearne @chrisfearne]

Honoured to chair this week the 6th Meeting of the Global Leaders Group @GLGAMR on Antimicrobial Resistance @WHO @WOAH @FAO @UNEP

[One Health Trust @OneHealthTrust]

January is #OneHealthAwarenessMonth. Why does #OneHealth matter? Find out in our #infographic.

Learn about OHT's future headquarters for One Health research, education, and action in our podcast with OHT's Ramanan Laxminarayan. Listen here:
https://t.co/uArsTE2osz

[IFPMA @IFPMA]

We are pleased to see new international investments by the industry backed @AMRActionFund toward accelerating antibiotic R&D to #beatAMR. Now, global policymakers must also step up & take action toward the development of new #antibiotics. More in @axios ⬇️

[AMR Action Fund @AMRActionFund]

We are thrilled to announce our investment into @BioVersys! The antibiotics they are developing target some of the highest-priority drug-resistant pathogens and could deliver significant benefits to patients suffering from life-threatening infections. https://t.co/GunkoIp57g #AMR

[One Health Trust @OneHealthTrust]

👏 Include vaccines in the fight against drug-resistant #superbugs. 👏

Let's say it louder for the folks in the back.

Learn why in our OWOH #podcast with Dr. David Heymann of @LSHTM_AMR @LSHTM

Listen here:
https://t.co/jVXuvwm0Mw
#fightamr #amr